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Abstract The dream of slowing down the aging process has
always inspired mankind. Since stem cells are responsible for
tissue and organ rejuvenation, it is logical that we should
search for encoded mechanisms affecting life span in these
cells. However, in adult life the hierarchy within the stem cell
compartment is still not very well defined, and evidence has
accumulated that adult tissues contain rare stem cells that pos-
sess a broad trans-germ layer differentiation potential. These
most-primitive stem cells—those endowed with pluripotent or
multipotent differentiation ability and that give rise to other
cells more restricted in differentiation, known as tissue-
committed stem cells (TCSCs) - are of particular interest. In
this review we present the concept supported by accumulating
evidence that a population of so-called very small embryonic-
like stem cells (VSELs) residing in adult tissues positively
impacts the overall survival of mammals, including humans.
These unique cells are prevented in vertebrates from prema-
ture depletion by decreased sensitivity to growth hormone
(GH), insulin (INS), and insulin-like growth factor (IGF) sig-
naling, due to epigenetic changes in paternally imprinted
genes that regulate their resistance to these factors. In this
context, we can envision nutrient response GH/INS/IGF sig-
naling pathway as a lethal factor for these most primitive stem
cells and an important culprit in aging.
Keywords Longevity . VSELs . HSCs . Growth hormone .
Insulin . Insulin-like growth factor . Parental imprinting .
Aging . Geroprevention
Introduction
During embryogenesis, early-development stem cells show a
broad spectrum of tissue differentiation. The most primitive
are totipotent stem cells, the fertilized oocyte (zygote) and the
first few blastomeres in the blastula, as these cells give rise to
the entire embryo proper and placenta [1]. A short time later in
development the totipotency of stem cells is lost, and a popu-
lation of pluripotent stem cells emerges in the inner cell mass
of the blastocyst, which gives rise to all embryonic tissues
except the placenta. Pluripotent stem cells are still present after
blastocyst implantation in the uterus in the epiblast, from
which the entire adult organism will develop. Next, among
the early-development stem cells in the epiblast, some give
rise to multipotent stem cells that may differentiate into cells
from two different germ layers (meso-, ecto-, or endoderm) or
show broad differentiation potential into cells derived from a
single germ layer [2].
Further on during embryogenesis these pluripotent or
multipotent stem cells became specified into tissue-
committed stem cells (TCSCs), which already possess a lim-
ited ability to differentiate, being restricted to a given lineage
(e.g., hematopoietic, epidermal, or neural). The proximal part
of the epiblast also gives rise to primordial germ cells (PGCs),
which, as precursors of gametes, carry developmental
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totipotency to the next generation [3]. As it will be discussed
later in this review, we and others have identified a population
of very small embryonic-like stem cells (VSELs) in postnatal
tissues that share several characteristics with migrating PGCs
[4–21]. The number of these cells in adult tissues seems to
correlate positively with life span, and VSELs are proposed as
a backup population for TCSCs in adult life [22–25].
One of the currently proven geropreventive measures is
caloric restriction, which induces GH resistance and reduces
insulin (INS) level [26–28]. Since GH stimulates liver to se-
crete insulin-like growth factor 1 (IGF-1), caloric restriction
leads also to a decrease in the level of IGF-1 circulating in
peripheral blood. Based on this, an important mechanism by
which caloric restriction extends life span is the decrease in
intensity of GH/INS/IGF-1 signaling [29, 30].
Since, as postulated above, VSELs are precursors of adult
TCSCs and are responsible for postnatal tissue and organ re-
juvenation, it is logical to assume that the robustness and
overall condition of these cells affects life span. In this review
we will present our working hypothesis, supported by previ-
ously generated data, that enhanced GH/INS/IGF signaling
leads to premature VSEL depletion, a decrease in robustness
of VSELs, and accelerates aging. Metaphorically speaking,
VSELs are continuously being depleted in the Bmetabolic
fire^ generated by GH/INS/IGF signaling throughout adult
life of the individual [3].
This concept has very important implications for justifying
the development of new prophylactic and treatment strategies
that are based on diminishing the unwanted Bmetabolic-side
effects^ of GH/INS/IGF signaling in VSELs as well as other
stem cells. These strategies involve i) caloric restriction, ii)
regular physical exercise, and iii) more specific drugs than
those currently available (e.g., metformin, berberine, or
rapamycin), which may inhibit this longevity-limiting path-
way [32, 33]. We predict that the stem cell compartment
targeting by pharmacotherapy to prevent premature depletion
of VSELs from adult tissues will become a valuable approach
to increasing human health- and life- span.
In this review we will first discuss side effects of enhanced
GH/INS/IGF signaling leading to aging of somatic cells and
stem cell compartment, and next we will focus on epigenetic
changes in parentally imprinted genes that attenuate this sig-
naling pathway in VSELs, protecting them from premature
depletion from adult tissues.
Aging as the Result of a Sequence of Several Adverse
Molecular andMetabolic EventsAging is an inevitable con-
sequence of life and it has been suggested that is
preprogrammed in the genes of all living organisms. It accel-
erates after achieving reproductive age, when the genes could
be passed on to the next generation. Several mechanisms are
currently proposed that accelerate this process, leading to the
same result as some researchers envision of culling adult or-
ganisms that have completed the reproductive period of life.
It is well known that after cells reach the Hayflick number
of divisions, their proliferative potential is exhausted, which is
reflected by shortening of the tips of their chromosomes
(called telomeres) [34]. The shortening of telomeres leads to
telomere dysfunction, genetic aberrations and impacts cell
proliferation than may end as replicative senescence. An im-
portant mechanism in the aging process is the generation of
reactive oxygen species (ROS), that contribute to replication
stress and oxidative DNA damage [35]. The ROS, generated
in mitochondria as a product of oxidative phosphorylation,
induce DNA damage including formation of the DNA
double-strand breaks. The latter cause the accumulation of
mutations. In this context, DNA in stem cells known to be
metabolically quiescent, is more effectively protected from
endogenous ROS compared to DNA in their progeny cells
[36]. However, with time, even in stem cells at the reduced
exposure to ROS, DNA undergoes progressive damage.
Accumulation of unrepaired or incorrectly repaired DNA le-
sions in stem cells lowers the genome integrity leading to loss
of fidelity of transcription and generation of proteins with
defective function in progeny cells. The lesions at the
telomeric DNA may affect cell longevity. It should be noted
that hyaluronic acid, which is the major constituent of stem
cell niche, by intercepting ROS protects stem cells from oxi-
dative damage by exogenous oxidants [37]
Another important mechanism responsible for aging is im-
pairment over time of the process of autophagy, a major deg-
radation pathway essential for removing damaged organelles
and macromolecules from the cytoplasm in eukaryotic cells,
which promotes recycling of amino acids during periods of
starvation [28, 38]. A decrease in autophagy activity leads to
accumulation of protein aggregates, which negatively affect
cell function and lead to damage and degeneration of mito-
chondria, thus contributing to aging [28].
In addition to the abovementioned molecular events, aging
is also affected by several other biological processes, such as
pathologic lipid metabolism and chronic inflammation [32,
39]. Aging is therefore a complex multigene-driven process
with individual susceptibility. However, the fact that mito-
chondrial ROS generation contributes to aging points toward
cell metabolic pathways as the basis of this process. In fact,
aging is tightly connected to the intensity of metabolic impact
of aerobic and anaerobic glycolysis, in which GH/INS/IGF
nutrient response signaling pathway plays a crucial role [26,
28, 40–42].
The Emerging Role of GH/INS/IGF-Regulated Pathways
to Explain Aging - Lessons fromAnimalModelsOne of the
most intriguing observations related to aging is that, in all
organisms, whenever there is a decrease in INS/IGF signaling
(invertebrates) or GH/INS/IGF signaling (vertebrates), there is
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an extension of life span [40–42]. This mechanism has been
observed in yeast, worms, fruit flies, and mice and also applies
to humans. The genes involved in this pathway, depending on
the particular species, may have different names, but all have
similar effects on intracellular metabolism by targeting corre-
sponding pathways.
The origin of this intriguing phenomenon is believed to
have emerged early during evolution as it is evident by its
presence in yeast. The main task of yeast, like every other
organism, is to reproduce and to pass genes on to the next
generation. Yeasts reproduce rapidly if there is enough carbo-
hydrate food available in their environment. Early in their
evolution, yeasts had to employ a defensive strategy when
there was a food shortage - namely to slow down metabolism
in order to survive until food again became available [40–42].
It has been proposed that this mechanism, developed during
evolution, affected pathways involved in carbohydrate metab-
olism that are regulated by INS and IGF signaling and resulted
in developing in vertebrates an anti-aging regulatory switch
between slowing down metabolic pathways and GH/INS/IGF
signaling. This evolutionarily ancient mechanism is clearly
visible in addition to yeasts, for example, in other mutants of
the INS/IGF pathway, and has been described in i)
Caenorhabditis elegans (roundworm), ii) Drosophila
melanogaster (fruit fly), and in the long living murine mutants
of the GH/INS/IGF pathway [40–43]. The affected individ-
uals are smaller in size but have an extended life span. Another
recent observation from the animal world comes from
Brandt’s bat, which may live up to 40 years. This bat is small
(~ 4–8 g of body mass) and displays similar mutations in the
GH/INS/IGF signaling pathway [44]. A similar mechanism
also operates in normal individuals not affected by obvious
mutations in GH/INS/IGF signaling pathways exposed for
example to caloric restriction, although at a much lower level
of activity.
Interesting models that support this mechanism include
long-living mutant mice that have well-defined mutations in
GH/INS/IGF signaling pathways. These mice are smaller in
size but live much longer than their normal littermates,
retaining fecundity for an extended period of life, and giving
rise to viable litters even at an advanced age. These murine
mutants are known in the literature as Laron, Ames, Snell, and
Blittle^ dwarf mice [24, 43].
The first strain, Laron dwarf mice are produced by targeted
disruption of the GH receptor and GH binding protein
encoding gene (GHR-KO or GHBP-KO mice) [43]. Despite
elevated GH levels in blood, these animals do not secrete
insulin-like growth factor 1 (IGF-1, also known as
somatomedin C) from the liver because of a lack of functional
GH receptors on hepatocytes. As a consequence of it, Laron
dwarf mice have undetectable levels of IGF-1 circulating in
peripheral blood, are smaller in size, but show a remarkable
extension in life span and prolonged fecundity [45]. Similarly,
long living are also GH releasing hormone deficient (GHRH−/
−) mice that also have very low level of IGF-1 circulating in
peripheral blood [46].
The other mutant animals, namely Ames and Snell dwarf
mice, lack GH, prolactin (PRL), and thyroid-stimulating hor-
mone (TSH) due to a defect in the Bpaired^-like homeodomain
pituitary transcription factor Prop1 that controls development
of anterior pituitary cells [47], live much longer than their
normal siblings, and exhibit many symptoms of delayed aging
[24]. Like Laron dwarfs, these mutants also have very low
levels of circulating IGF-1 in peripheral blood. Similarly, sol-
itary GH deficiency in Blittle^ mice is also associated with
increased life span and a decrease in IGF-1 levels circulating
in peripheral blood [26].
Of importance for the topic of this review is our observa-
tion that the mentioned above long living mice during their
life maintain a higher number of VSELs in bone marrow,
compared to their normal littermates [24, 25].
Another animal example is the prolonged longevity of
RasGRF1-deficient and ribosomal protein S6 kinase 1
(S6 K1)-deficient mice [48–51]. Both RasGRF1 and S6 K1
are downstream signaling targets of GH/INS/IGF pathway.
While RasGRF1 is a small GTP exchange factor molecule
associated with the IGF-1 and INS receptors [48, 49], S6 K1
is involved in signaling from serine/threonine kinase - known
as mechanistic target of rapamycin (mTOR) [51]. On the other
hand, life span in wild type murine strains can be increased by
pharmacological modulation of INS and IGF-1 receptor sig-
naling with metformin [28, 32, 52] or by inhibition of mTOR,
located downstream of both receptors (Fig. 1) [28, 32]. In
contrast to attenuating GH/INS/IGF pathways, an increase in
signaling from this axis, as seen in mice transgenic for GH or
mice that are administered IGF-1 for a prolonged period, leads
to accelerated aging and shortening of life span [26, 42]. In
contrast these short living animals exposed permanently to
high level of circulating in peripheral blood IGF-1, have as
demonstrated significantly reduced number of VSELs in adult
tissues [24, 25].
Based on the animal models discussed above, these studies
provided important evidence for the role of the GH/INS/IGF
signaling axes in regulating life span and affecting aging. The
main question remains: How relevant are data obtained in
mutant murine models to other larger animals? Some indirect
evidence that GH/INS/IGF signaling plays a role in other spe-
cies is the observation that smaller dogs have enhanced lon-
gevity compared with larger dogs [53]. In support of this cor-
relation, the most long-living canine is the Chihuahua
(~18 years, 15–25 cm tall, 2 kg body mass), and the one with
shortest life span is the Irish wolfhound (~7 years, 80 cm tall,
54 kg bodymass). These data, however, have to be interpreted
with caution, because they may also depend on inbred defects
in these animals and possibly other factors. Nevertheless, lon-
gevity has been also described in small mixed bred dogs [53].
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Thus, the overall rule appears to indicate that smaller dogs live
longer. The molecular mechanisms behind this intriguing fact
are most likely metabolism dependent, and it would be worth-
while to study the metabolism of these animals and its rela-
tionship with the intensity of GH/INS/IGF signaling. It would
be interesting to compare tissue reserve of VSELs between
these animals.
As mentioned earlier, the progressive DNA damage by
ROS has been considered as one of the mechanisms contrib-
uting to aging (BROS mechanism^). However, with a few
exceptions [54, 55] the evidence that antioxidants or other
means of prevention of oxidative DNA damage can extend
the lifespan or reduce the symptoms of aging, is scarce [56].
On other hand, as cited above, the evidence that the constitu-
tive signaling along the axis GH/INS/IGF–mTOR–S6 K1
(BTORmechanism^) is the driving force that accelerates aging
is compelling.
It should be noted that there is an association between the
ROS and mTOR mechanisms that relates to aging and DNA
damage. Specifically, the persistent activation of
mTOR/S6 K1 pathway is associated with translation that re-
quires constant generation of ATP. This in turn involves en-
hanced oxidative phosphorylation which leads to formation of
ROS and oxidative DNA damage. The damage of oncogenes
or tumor suppressor genes may lead to neoplastic transforma-
tion. Consistent with this are observations that antioxidants
have chemopreventive properties [57, 58], while as already
mentioned, have relatively minor impact on longevity.
Do Body Size and GF/INS/IGF Signaling Affect Life Span
in Humans? An increase in body size correlates with en-
hanced metabolic activity and more intense developmental
engagement of the stem cell compartment, and similar studies
investigating whether there is a correlation between body size
and longevity have also been performed in humans [59].
Again, these reports have to be interpreted with caution, be-
cause in humans there are several genetic factors that affect
average life span. Nevertheless, the available data indicate that
shorter height and lower body mass correlate with prolonged
life span. For example, a negative correlation between height
and life span in professional baseball players in the USA has
been shown as well as a negative effect of height on overall
survival in the French population [59]. Likewise, there are
observations that shorter American men of Japanese ancestry
live longer than their taller counterparts [60]. Indirect evidence
also suggests that there are low IGF-1 levels in the PB of
human centenarians [61] and data that people from long living
families have lower level of circulating GH [62]. In addition,
there have been described functional mutations of IGF-1 re-
ceptor lowering its effectiveness in centenarians that as postu-
lated prolongs longevity of these individuals [63].
An important and somewhat underappreciated indirect in-
dicator of the role of IGF-1 in aging is measurement of the red
blood distribution width (RDW), a component of the complete
blood count indicating the size heterogeneity of the erythro-
cytes circulating in peripheral blood [64]. A higher RDW that
is associated with a shorter life span is result of the well-
known positive stimulating of IGF-1 on erythropoiesis, and
indicates indirectly a role of elevated IGF-1 level in blood in
senescence [65]. Based on this it has been proposed that pa-
tients with higher circulating IGF-1 levels have higher RDW
and that this correlates with a decrease in life span [64].
Additional indirect evidence is the relative absence of tall
individuals in populations of human centenarians [59].
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Fig. 1 GH/INS/IGF signaling-dependent metabolic pathways that
impact aging in all somatic cells and stem cells. A highly caloric diet
and low levels of physical activity enhance GH/INS/IGF signaling in
somatic cells in mTOR/mTORC1-dependent manner, including stem
cells. The main role of mTORC1 is to activate and control translation of
proteins and to exert this function TORC1 functions as a nutrient/energy/
redox sensor that requires adequate energy resources, nutrient availability
and oxygen abundance. However, over time, this leads to damaging,
mTOR-activated intracellular processes due to e.g., ROS-mediated
telomeric DNA oxidative damage, lipid peroxidation, inhibition of
autophagy. The beneficial effects of AMPK activators that inhibits
mTORC1 (e.g., metformin and berberine) and direct mTOR inhibitors
(e.g., rapamycin) are indicated. As will be demonstrated in Fig. 2, due
to epigenetic changes in methylation state of some parentally imprinted
genes VSELs, similarly as PGCs are more resistant to GH/INS/IGF
signaling as compared to other TCSCs and somatic cells
446 Stem Cell Rev and Rep (2017) 13:443–453
Moreover, Okinawans, who are on average ~ 10–13 cm
shorter than Scandinavians, have the highest proportion (500
per million) of centenarians in the world [59]. A similar find-
ing has been reported for a population of short centenarians
living on Krk Island on the Adriatic Sea [66]. It has been
shown that these Blittle people of Krk^ carry the same muta-
tion of transcription factor Prop1 which controls development
of anterior pituitary GH secreting cells as long living Ames
dwarf mice [50].
Again, this evidence should be interpreted with caution, as
it could be explained by several factors, such as the beneficial
effects of a fish-enriched diet in Japan or of a Mediterranean
diet on Krk Island. Nevertheless, these examples may also
provide some hints about the role of GH/INS/IGF signaling
and metabolic activity and potential impact on overall VSELs
content in these individuals.
Key Metabolic Pathways Related to Cellular Senescence
and Aging As presented above, GH/INS/IGF signaling clear-
ly affects aging. Figure 1 shows pathways activated through
the GH-, INS-, and IGF-receptors as part of a nutrient-sensing
response that converges on the serine/threonine kinase mTOR
- a master regulator of cell growth, metabolic function, au-
tophagy, and metabolism - in response to nutrient-activated
GH/INS/IGF signaling [28, 52]. It is well accepted that
mTOR modulates the ratio between anabolic and catabolic
processes in response to nutrient availability and overall cel-
lular energy status [28, 52].
At the molecular level, mTOR functions in two distinct
complexes: mTOR complex 1 (mTORC1) and mTOR com-
plex 2 (mTORC2) [52]. mTORC1 is a protein complex com-
posed by mTOR itself and few other regulatory proteins. Its
main role is to activate and control synthesis of proteins and to
exert this function TORC1 acts as a nutrient/energy/redox
sensor that evaluates adequate energy resources, nutrient
availability and oxygen abundance [28, 52]. mTORC1 is
inhibited by rapamycin and its analogs (rapalogs), which leads
to inhibition of mRNA translation and protein synthesis due to
a negative effect on the twomTORC1 substrates, S6 K1 (men-
tioned above) and eukaryotic translation initiation factor 4E
binding protein 1 (4E–BP1) [52]. This places mTOR
(TORC1) complex signaling at center stage as an evolution-
arily conserved regulator of life span Fig. 1 [28, 52]. In sup-
port of this role, inhibition of this regulatory complex by
rapamycin or its analogs extends life span in several animal
models, including yeast, round worms, fruit flies, and mice. In
contrast to mTORC1, mTORC2 pathway is mainly involved
in regulation of cytoskeleton, however may also affect longev-
ity by inhibiting FOXO3a signaling [52]. However, there are
some observations that TORC2 signaling may be beneficial
for longevity and inhibition of TORC2 is in particular detri-
mental to males [67]. This opposite effects of TORC1 and
TORC2 inhibition may explain in part why interventions that
decrease mTOR signaling e.g., by rapamycin show greater
efficacy in females [67].
As mentioned above, mice with a mutation in S6 K1 have
an extended life span. Importantly, this beneficial effect of
caloric restriction or S6 K1 mutation on life span can be ex-
plained by reduced mTORC1 activity downstream of GH/
INS/IGF signaling (Fig. 1) [28, 52]. Moreover, both pharma-
cologic and genetic disruptions of this regulatory complex are
sufficient to extend lifespan in several species, including mice
under non-dietary restriction conditions. It has been reported
that the mTORC1 complex is negatively regulated by adeno-
sine monophosphate-activated protein kinase (AMPK), a key
sensor of cellular energy status [68–70]. This kinase is an
evolutionarily conserved sensor of cell metabolism and is ac-
tivated by low levels of ATP. AMPK overexpression or its
activation by plant-derived compounds, such as metformin,
berberine, or some chemically synthesized small-molecule ac-
tivators, has been reported to extend life span in experimental
animal models [69, 70]. This effect is due to AMPK-mediated
inhibition of GH/INS/IGF signaling in mTORC1-dependent
manner (Fig. 1). Interestingly, we noticed that prolonged ad-
ministration of metformin increases a number of VSELs in
adult murine bone marrow.
Several clinical trials are currently being run using mTOR
inhibitors, such as rapamycin or its rapalogs, as well as AMPK
activators, including metformin and berberine, to extend hu-
man life span [68–71]. In order to collect definitive data, long-
term studies have to be completed. It should be noted however
that the direct target for metformin and berberine is respiratory
complex I of electron transport chain in mitochondria. Its in-
hibition by either of these drugs precludes formation of ATP
and thereby leads to an increase of AMP/ATP ratio. The latter
provides the trigger activating AMPK which in turn inhibits
mTOR signaling [72]. Considering the above mechanism
these drugs, in addition to inhibiting mTOR, by preventing
oxidative respiration also suppress formation of ROS.
Interestingly, we noticed that prolonged administration of
metformin increases a number of VSELs in adult murine bone
marrow.
The Unexpected Role of Class III Histone Deacetylases
(Sirtuins) and their Role in Prolonging Life Span Histone
deacetylases (HDACs) are enzymes that remove acetyl groups
on histones, which allows these proteins to wrap DNA around
core histones of nucleosome more tightly [73]. HDACs also
exert other pleiotropic effects in cells by interacting with in-
tracellular targets. The most intriguing among the HDACs are
the class III enzymes, which in mammals consist of seven
members (SIRT-1–7) that emerged during evolution from the
yeast Sir2 gene [73].
Of the seven mammalian sirtuins, SIRT-1 is the closest
homolog of yeast Sir2 and is the most-studied mammalian
sirtuin. SIRT-1 predominantly localizes to the cell nucleus
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and shows several pleiotropic effects beside its role in histone
deacetylation [74–76]. Specifically, it may deacetylate p53
and peroxisome proliferator-activated receptor gamma coacti-
vator 1-alpha (PGC1α) and thus inhibit apoptosis and enhance
mitochondrial function and biogenesis, respectively.
Moreover, the SIRT-1-regulated acetylation state of FOXO
transcription factors is thought to selectively direct these fac-
tors to certain targets in the cell and to regulate cell metabo-
lism and stress responses [74, 75]. Other newly identified
novel functions of SIRT-1 include i) neuroprotection, ii)
liver regeneration, and iii) delayed replicative senescence
of fibroblasts [74].
There are several studies demonstrating a positive effect by
SIRT-1 in prolonging longevity, which can be explained in the
context of GH/INS/IGF signaling and caloric restriction. SIRT-
1 is reportedly stimulated by resveratrol, although the reality of
this latter effect is still under debate [74]. What is highly rele-
vant for the topic of this review, SIRT-1 also chaperones a de
novo methyltransferase known as DNMT3L [76–78], a mech-
anism that maintains quiescent state of VSELs and prevents
their proliferation [22].We noticed that inhibition of SIRT-1 by
nicotinamide or valporic acid leads to increase in proliferation
of VSELs both in vivo and in vitro cultures [22]. Interestingly,
an inhibition of SIRT-1 by nicotinamide or valporic acid has
been recently postulated to play an important role in promoting
efficient expansion of human LT-HSCs [79–83]. This may be
related as we will discuss below to expansion of VSELs, that
could be specified into long term repopulating hematopoietic
stem cells (LT-HSCs) [83, 84].
Effects of Changes in GH/INS/IGF Signaling on the Stem
Cell CompartmentWhile all these discussed above effects of
GH/INS/IGF signaling apply to all somatic cells, at the same
time they are also highly relevant for stem cells as well.
To assess the effect of GH/INS/IGF signaling on stem cells,
we evaluated the hematopoietic stem cell (HSC) compartment
in Laron and Ames dwarf mice and observed that these mice,
with undetectable plasma levels of circulating IGF-1, have an
enhanced number of LT-HSCs and hematopoietic progenitors
compared with control littermates [24, 25]. By contrast, the
number of HSCs was reduced in GH transgenic mice, which
have enhanced GH/INS/IGF signaling due to high levels of
circulating IGF-1 in peripheral blood [24]. Our observations
were recently confirmed in an elegant study by another group
[85]. We also reported that prolonged caloric restriction and
physical activity enhances the number of HSCs in wild type
mice [86, 87]. This effect is again most likely related to atten-
uation of GH/INS/IGF signaling [29, 30].
In our studies, an increase in the number of HSCs in i)
Laron and Ames dwarf animals, ii) wild type mice under
prolonged caloric restriction, and iii) mice subjected to regular
daily physical activity correlated with an increase in the num-
ber of VSELs [86, 87]. This is highly important, because, as
we and others have demonstrated, VSELs are precursors of
long term repopulating HSCs (LT-HSCs) [83, 84].
Interestingly, other investigators have also reported that
prolonged caloric restriction had a positive effect on the num-
ber of skeletal muscle stem cells [88] and that physical activity
increases the number of neural stem cells in the brain [89]. The
potential involvement of VSELs in these latter phenomena
requires further studies.
The adult stem cell compartment has also been evaluated in
other experimental models of murine longevity, and these re-
sults corroborate the concept that augumented GH/INS/IGF
signaling has a negative effect on these cells. For example,
enhanced hematopoietic potential and LT-HSC activity have
been reported in mentioned above mouse S6 K1 mutants [51],
which display defective signaling downstream from the
mTORC1 (Fig. 1). Moreover, in vivo administration of an
mTORC1 inhibitor, rapamycin, leads to rejuvenation of
HSCs and intestinal stem cell functions in older animals
[90–92]. Unpublished results from our group revealed as men-
tioned above an increase in the number of VSELs and HSCs
in mice treated for a prolonged period of time with metformin,
which, negatively affects mTORC1 via AMPK and addition-
ally activates SIRT-1.
The most intriguing results, however, are from animals
with manipulated sirtuin expression [93, 94]. Specifically,
while upregulation of SIRT1 by small-molecule activators
(SRT1720 or SRT3025) had a beneficial effect on extending
life span and expanding HSCs inwild typemice [91, 92], mice
with inducible hematopoietic SIRT-1 knockout displayed ac-
celerated hematopoietic aging due to an accelerated decrease
in the number of HSCs [93, 94]. These results indicate that
SIRT-1 is a guardian of HSCs during life. Similar results were
recently observed in SIRT-3-KO and SIRT-7-KO animals [95,
96], and it would be interesting to evaluate quantity of VSELs
in tissues of these animals.
Aging, the Stem Cell Compartment, and GH/INS/IGF
Signaling from the Perspective of very Small Embryonic-
like StemCells (VSELs) Residing in Adult TissuesAsmen-
tioned above, evidence has accumulated for the scenario that
during embryogenesis stem cells related to epiblast stem cells
or migrating PGCs escape specification into TCSCs. Instead,
they retain pluripotent character and survive as a population of
VSELs into adulthood, forming a reserve pool of precursors
for TCSCs in adult issues [22, 97–99].
These small cells are slightly smaller than mature erythro-
cytes and have been purified by multiparameter flow cell
sorting from adult tissues, including bone marrow, umbilical
cord blood, and mobilized peripheral blood, and are very well
characterized at the molecular level [97–99]. In addition to
hematopoietic tissues they are also detected in adult organs,
including gonads, brain, liver, heart, and skeletal muscles
[100]. The small size of these cells (~3–5 μm in mice and
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4–7 μm in humans) and the paucity of mitochondria are signs
of their quiescence and low metabolic activity [97–99]. BM-
isolated VSELs have been shown to remain as precursors of
TCSCs for several types of cells, including hematopoietic
cells, mesenchymal cells, endothelial cells, lung alveolar epi-
thelial cells, and cardiomyocytes [11–18, 83, 84]. At the same
time, VSELs isolated from murine and human gonads have
been proposed to be precursors of male and female gametes
[6, 8–10].
Murine and human BM-derived VSELs: i) are very rare
(~0.01–0.001% of nucleated BM cells); ii) express several
pluripotent stem cell markers, including Oct4, Nanog, Rex-
1, and SSEA-1 (murine VSELs) or SSEA-4 (human VSELs);
iii) contain sparse, round mitochondria; and iv) have large
nuclei filled with unorganized euchromatin [4, 5]. Evidence
from our and other groups indicates that VSELs are a popula-
tion of migratory cells, and their number increases in periph-
eral blood during stress situations related to tissue or organ
injuries [22]. Therefore, besides being a backup population for
TCSCs in adult life, VSELs may play a physiologically im-
portant surveillance role in repairing certain minor tissue in-
juries [22, 23].
What is most relevant to the topic of this review, the highly
quiescent state of VSELs in adult tissues is regulated by epige-
netic changes in certain paternally imprinted genes that are in-
volved in GH/INS/IGF signaling (Fig. 2). Overall, epigenetical-
ly regulated parental genomic imprinting is an important mech-
anism that ensures the parent-of-origin-specific monoallelic
transcription of parentally imprinted genes (depending on
whether the gene is from the maternally or paternally inherited
chromosome) and plays a crucial role in embryogenesis and the
pluripotency of early-development stem cells, includingVSELs
[97]. The expression of parentally imprinted genes is regulated
by DNA methylation at differentially methylated regions
(DMRs), which are CpG-rich cis-regulatory elements within a
particular parental gene locus [101].
It has been demonstrated that VSELs residing in adult tis-
sues erase some of the paternally methylated imprints (e.g., at
the mouse Igf2–H19 and Rasgrf1 loci); however, at the same
time they hypermethylate some of the maternally methylated
imprints (e.g., at the mouse locus encoding the Igf2 receptor
[Igf2R] and at the mouse Kcnq1-p57KIP2 and Peg1 loci) [97].
As a result of these epigenetic changes in the methylation state
of DMRs in paternally imprinted genes, VSELs highly ex-
press growth-repressive genes (H19, p57KIP2, and Igf2R) and
at the same time downregulate growth-promoting genes (Igf2
and Rasgrf1) [97]. What is important for topic of this review,
several of these genes are involved in GH/INS/IGF signaling
[31, 97].
Of particular interest is the Igf2-H19 locus, which encodes
insulin-like growth factor 2 (IGF-2), and this protein ligand
signals through the IGF-1 and INS receptors [101]. The same
locus also transcribes the non-coding RNA H19, which gives
rise to several miRNAs, including miR675-3p and miR675-
5p, and these downregulate expression of the respective IGF-1
and INS receptors on VSELs (Fig. 2) [31, 97]. Another gene
locus affected by epigenetic erasure of DMRs is Rasgrf1,
which encodes a small GTP exchange factor involved in sig-
naling from the IGF-1 and INS receptors [31, 48, 49].
Moreover, epigenetic changes in VSELs due to hypermethy-
lation at the maternally imprinted Igf2-R locus also lead to
upregulation of the IGF-2 receptor, which is not a signaling
receptor and serves as a Bmolecular bin^ to prevent interaction
of IGF-2 with the IGF-1 and INS receptors [31].
Therefore, epigenetic reprograming changes observed in
VSELs lead to a decrease in GH/INS/IGF signaling in these
cells, keeping them in a quiescent state and preventing their
premature depletion in adult tissues [31]. These epigenetic
changes may be additionally enhanced by caloric restriction
and regular physical activity [85–89] as well as by adminis-
tration of certain drugs, including metformin, berberine, or
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Fig. 2 Changes in the methylation state of parentally imprinted genes
lead to attenuation of GH/INS/IGF signaling in VSELs. VSELs are
deposited in adult tissues as a backup population for tissue-committed
stem cells (TCSCs). Due to erasure of paternal imprinting at the Igf2-H19
locus, VSELs do not express endogenous IGF-2 and, through the activity
of H19 gene-derived miRNA675, downregulate expression of the IGF-1
and INS receptors, which decreases their sensitivity to the circulating
IGF-1, INS and IGF-2 activating GH/INS/IGF signaling axis. At the
same time, due to hypermethylation of the DMR at the Igf2R locus by
upregulating expression of the non-signaling IGF-2 receptor (which
serves as molecular bin for IGF-2), these cells additionally attenuate
responsiveness to circulating IGF-2. During aging, gradual
hypermethylation at the Igf2-H19 locus is observed, which leads to an
increase in expression of autocrine IGF-2 and a decrease in H19-
expressed miR675, which leads to an increase in expression of the IGF-
1 and INS receptors. This results in age-related increased sensitivity to
GH/INS/IGF signaling and age-mediated VSEL depletion. As a
consequence, there is a decrease in VSEL-generated TCSCs, which
impairs tissue and organ rejuvenation. Moreover, VSELs deposited in
adult tissues may, over time, become more quickly depleted by
chronically elevated circulating levels of IGF-1 and INS, which engage
the IGF1R and INSR expressed by these cells. This mechanism may
contribute to accelerated aging observed in situations with high
circulating levels of IGF-1 and INS (e.g., high calorie uptake)
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rapamycin [68–71]. This quiescent state of VSELs is also
most likely promoted by other activators of AMPK as well
as of SIRT-1 [74, 75].
Interestingly, as mentioned above an inhibition of SIRT-1
by nicotinamide or valporic acid has been recently postulated
to play an important role in promoting an efficient expansion
of human LT-HSCs [79–82]. Since SIRT-1 is a chaperone of
DNMT3L [77, 78], and DNMT3L is required for re-
methylation of erased regulatory loci at parentally imprinted
genes including Igf2-H19 [31], we postulate that expansion of
LT-HSCs in presence of nicotinamide or valporic during
SIRT-1 inhibition occurs from expanded VSELs.
This differentiation of VSELs into LT-HSCs, as we have
proposed, is fostered by re-methylation of erased loci in pa-
rentally imprinted genes that leads e.g., to increase in expres-
sion of IGF2 and downregulation of H19 [31]. Our data was
recently confirmed in an elegant in vivo murine model by
independent group of investigators who demonstrated that
maternal type of methylation state - erasure of imprinting at
Igf2-H19 loci regulates quiescence of LT-HSCs [102].
We propose that modulation of VSEL robustness in various
adult tissues is crucial for therapeutic strategies to prolong life
span. VSEL robustness also explains at the stem cell level the
role of GH/INS/IGF signaling in aging. Based on this reason-
ing, VSELs are at center stage as a crucial target for better
understanding the effects of different strategies attenuating
GH/INS/IGF signaling in promoting longevity [103]. These
strategies include caloric restriction, physical activity, and the
effect of drugs that attenuate GH/INS/IGF signaling [68–71,
85–89]. A decline in the number of VSELs residing in adult
tissues as result of an increase in GH/INS/IGF signaling, e.g.,
due to a high caloric diet or a low level of physical activity,
results in accelerated aging. An important gatekeeper to pre-
vent premature depletion of VSELs and to keep them quies-
cent is SIRT-1. This may explain beneficial effects of metfor-
min, berberine and rapamycin as drugs that promote longev-
ity. On other hand by inhibiting SIRT-1 using valporic acid or
nicotinamide we were recently able to force VSELs to prolif-
erate and expand ex vivo for potential therapeutic purposes in
chemically defined in vitro cultures [22].
Nevertheless, this epigenetic modulation of expression of
genes involved in GH/INS/IGF signaling that protects VSELs
from premature depletion from adult tissues is attenuated as
demonstrated in mice with age due to gradual methylation of
erased DMRs at Igf2-H19 and RasGrf1 loci [24]. This mech-
anism contributes to age-dependent depletion of VSELs, and
as we envision contributes to aging.
Conclusions
We have presented evidence indicating that strong GH/INS/
IGF signaling has an accelerating effect on aging and leads to
a decrease in stem cell number including VSELs. Therefore,
by targeting GH/INS/IGF signaling using highly specific in-
hibitors, we may be able to develop new, potent, and side
effect-free therapeutic strategies that could fulfill the dream
of an Bambrosia^ or Bfountain of youth^ to prolong human
both life span and health span. The strategies may also involve
regenerative medicine employing VSELs harvested at young
age or individual’s cells harvested, genetically reprogrammed,
expanded in vitro, and used for autologous transplant. One
possible approach would be to harvest stem cells from the
umbilical blood of the newborn, store it cryogenically and
use when the donor reaches an old age in hope of
Brejuvenation^ of at least some his/her organs or functions.
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